Borthakur G, Ravandi F, Patel K, Wang X, et al. Retrospective comparison of survival and responses to Fludarabine, Cytarabine, GCSF (FLAG) in combination with gemtuzumab ozogamicin (GO) or Idarubicin (IDA) in patients with newly diagnosed core binding factor (CBF) acute myelogenous leukemia: MD And Am J Hematol 2022 Aug 26. doi: 10.1002/ajh.26700.
PMID: 36053747